高级检索
当前位置: 首页 > 详情页

Short-term radiotherapy plus chemotherapy for locally advanced rectal cancer: 5-year outcomes of the phase III clinical trial (NCT02533271)

| 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,State Key Lab Mol Oncol, Beijing, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Radiat Oncol, Beijing, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Colorectal Surg, Beijing, Peoples R China [4]Shanxi Med Univ, Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Shanxi Hosp,Canc Hosp,Dept Radiobiol, Taiyuan, Peoples R China [5]Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res,Dept Radiat, Beijing, Peoples R China [6]Univ Chinese Acad Sci, Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp,Inst Basic Med & Canc IBMC,Dept Radiat O, Hangzhou, Peoples R China [7]Jilin Univ, China Japan Union Hosp, Dept Radiat Oncol, Changchun, Peoples R China [8]Sichuan Univ, West China Hosp, Dept Radiat Oncol, Chengdu, Peoples R China [9]Hunan Canc Hosp, Dept Radiat Oncol, Changsha, Peoples R China [10]Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China [11]Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Radiat Oncol, Div Life Sci & Med, Langfang, Anhui, Peoples R China [12]Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Peoples R China [13]Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Natl Ctr Gerontol,Dept Radiat Oncol, Beijing, Peoples R China [14]Sichuan Prov Canc Hosp, Dept Radiat Oncol, Chengdu, Peoples R China [15]Qinghai Red Cross Hosp, Dept Radiat Oncol, Xining, Qinghai, Peoples R China [16]Guizhou Med Univ, Affiliated Hosp, Dept Oncol, Guiyang, Peoples R China [17]Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Div Biostat & Bioinformat, Baltimore, MD USA [18]Air Force Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian, Peoples R China [19]Jilin Prov Canc Hosp, Dept Radiat Oncol, Changchun, Peoples R China [20]Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou, Peoples R China [21]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Radiat Oncol, Shenzhen, Peoples R China [22]Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen, Peoples R China
出处:
ISSN:

关键词: Rectal cancer Phase III trial 5-year outcome

语种:
WOS:
中科院分区:
出版当年[2025]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学 2 区 核医学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学 2 区 核医学
JCR分区:
出版当年[2024]版:
Q1 ONCOLOGY Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2024]版:
Q1 ONCOLOGY Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

影响因子: 最新[2024版] 最新五年平均 出版当年[2025版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,State Key Lab Mol Oncol, Beijing, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Radiat Oncol, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Acute Toxicities Comparison of Postoperative Chemoradiation Therapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase 3 Trial [2]A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare) [3]A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare). [4]Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR). [5]Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial [6]Final overall survival and updated biomarker analysis results from the randomized phase III ICOGEN trial. [7]Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703). [8]A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast Cancer [9]Multicenter randomized double-blind phase III trial of donafenib in progressive radioactive iodine-refractory differentiated thyroid cancer [10]A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号